163 related articles for article (PubMed ID: 29759728)
1. Synthesis and evaluation of a ring-constrained Hsp90 C-terminal inhibitor that exhibits neuroprotective activity.
Zhang Z; You Z; Dobrowsky RT; Blagg BSJ
Bioorg Med Chem Lett; 2018 Sep; 28(16):2701-2704. PubMed ID: 29759728
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and evaluation of novologues as C-terminal Hsp90 inhibitors with cytoprotective activity against sensory neuron glucotoxicity.
Kusuma BR; Zhang L; Sundstrom T; Peterson LB; Dobrowsky RT; Blagg BS
J Med Chem; 2012 Jun; 55(12):5797-812. PubMed ID: 22702513
[TBL] [Abstract][Full Text] [Related]
3. Development of noviomimetics that modulate molecular chaperones and manifest neuroprotective effects.
Forsberg LK; Anyika M; You Z; Emery S; McMullen M; Dobrowsky RT; Blagg BSJ
Eur J Med Chem; 2018 Jan; 143():1428-1435. PubMed ID: 29137866
[TBL] [Abstract][Full Text] [Related]
4. Modulating Molecular Chaperones Improves Mitochondrial Bioenergetics and Decreases the Inflammatory Transcriptome in Diabetic Sensory Neurons.
Ma J; Pan P; Anyika M; Blagg BS; Dobrowsky RT
ACS Chem Neurosci; 2015 Sep; 6(9):1637-48. PubMed ID: 26161583
[TBL] [Abstract][Full Text] [Related]
5. Targeting Heat Shock Protein 70 to Ameliorate c-Jun Expression and Improve Demyelinating Neuropathy.
Zhang X; Li C; Fowler SC; Zhang Z; Blagg BSJ; Dobrowsky RT
ACS Chem Neurosci; 2018 Feb; 9(2):381-390. PubMed ID: 29120605
[TBL] [Abstract][Full Text] [Related]
6. Synthesis of paramagnetic ligands that target the C-terminal binding site of Hsp90.
Birar VC; Gelis I; Zuo A; Blagg BSJ
Bioorg Med Chem Lett; 2020 Aug; 30(16):127303. PubMed ID: 32631523
[TBL] [Abstract][Full Text] [Related]
7. KU-596 decreases mitochondrial superoxide and improves bioenergetics following downregulation of manganese superoxide dismutase in diabetic sensory neurons.
You Z; Zhang Z; Blagg BSJ; Dobrowsky RT
Exp Neurol; 2019 Mar; 313():88-97. PubMed ID: 30557564
[TBL] [Abstract][Full Text] [Related]
8. Novobiocin and additional inhibitors of the Hsp90 C-terminal nucleotide-binding pocket.
Donnelly A; Blagg BS
Curr Med Chem; 2008; 15(26):2702-17. PubMed ID: 18991631
[TBL] [Abstract][Full Text] [Related]
9. Inhibiting heat-shock protein 90 reverses sensory hypoalgesia in diabetic mice.
Urban MJ; Li C; Yu C; Lu Y; Krise JM; McIntosh MP; Rajewski RA; Blagg BS; Dobrowsky RT
ASN Neuro; 2010 Aug; 2(4):e00040. PubMed ID: 20711301
[TBL] [Abstract][Full Text] [Related]
10. Stimulation of heat shock protein 90 chaperone function through binding of a novobiocin analog KU-32.
Chatterjee BK; Jayaraj A; Kumar V; Blagg B; Davis RE; Jayaram B; Deep S; Chaudhuri TK
J Biol Chem; 2019 Apr; 294(16):6450-6467. PubMed ID: 30792306
[TBL] [Abstract][Full Text] [Related]
11. C-terminal heat shock protein 90 inhibitor decreases hyperglycemia-induced oxidative stress and improves mitochondrial bioenergetics in sensory neurons.
Zhang L; Zhao H; Blagg BS; Dobrowsky RT
J Proteome Res; 2012 Apr; 11(4):2581-93. PubMed ID: 22413817
[TBL] [Abstract][Full Text] [Related]
12. A Novel Class of Hsp90 C-Terminal Modulators Have Pre-Clinical Efficacy in Prostate Tumor Cells Without Induction of a Heat Shock Response.
Armstrong HK; Koay YC; Irani S; Das R; Nassar ZD; ; Selth LA; Centenera MM; McAlpine SR; Butler LM
Prostate; 2016 Dec; 76(16):1546-1559. PubMed ID: 27526951
[TBL] [Abstract][Full Text] [Related]
13. Heat Shock Protein 70 (HSP70) Induction: Chaperonotherapy for Neuroprotection after Brain Injury.
Kim JY; Barua S; Huang MY; Park J; Yenari MA; Lee JE
Cells; 2020 Sep; 9(9):. PubMed ID: 32887360
[TBL] [Abstract][Full Text] [Related]
14. Novobiocin induces a distinct conformation of Hsp90 and alters Hsp90-cochaperone-client interactions.
Yun BG; Huang W; Leach N; Hartson SD; Matts RL
Biochemistry; 2004 Jun; 43(25):8217-29. PubMed ID: 15209518
[TBL] [Abstract][Full Text] [Related]
15. Design, synthesis, and biological evaluation of ring-constrained novobiocin analogues as hsp90 C-terminal inhibitors.
Garg G; Zhao H; Blagg BS
ACS Med Chem Lett; 2015 Feb; 6(2):204-9. PubMed ID: 25699150
[TBL] [Abstract][Full Text] [Related]
16. Design, synthesis and biological evaluation of biphenylamide derivatives as Hsp90 C-terminal inhibitors.
Zhao H; Garg G; Zhao J; Moroni E; Girgis A; Franco LS; Singh S; Colombo G; Blagg BS
Eur J Med Chem; 2015 Jan; 89():442-66. PubMed ID: 25462258
[TBL] [Abstract][Full Text] [Related]
17. C-terminal modulators of heat shock protein of 90 kDa (HSP90): State of development and modes of action.
Bickel D; Gohlke H
Bioorg Med Chem; 2019 Nov; 27(21):115080. PubMed ID: 31519378
[TBL] [Abstract][Full Text] [Related]
18. Modified biphenyl Hsp90 C-terminal inhibitors for the treatment of cancer.
Forsberg LK; Liu W; Holzbeierlein J; Blagg BSJ
Bioorg Med Chem Lett; 2017 Sep; 27(18):4514-4519. PubMed ID: 28844386
[TBL] [Abstract][Full Text] [Related]
19. Towards the In-silico Design of New HSP90 Inhibitors: Molecular Docking and 3D-QSAR CoMFA Studies of Tetrahydropyrido [4, 3-d] Pyrimidine Derivatives as HSP90 Inhibitors.
Sepehri B; Ghavami R
Med Chem; 2018; 14(5):439-450. PubMed ID: 29564982
[TBL] [Abstract][Full Text] [Related]
20. Abrogation of heat shock protein 70 induction as a strategy to increase antileukemia activity of heat shock protein 90 inhibitor 17-allylamino-demethoxy geldanamycin.
Guo F; Rocha K; Bali P; Pranpat M; Fiskus W; Boyapalle S; Kumaraswamy S; Balasis M; Greedy B; Armitage ES; Lawrence N; Bhalla K
Cancer Res; 2005 Nov; 65(22):10536-44. PubMed ID: 16288046
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
